transient receptor potential cation channel, subfamily V, member 2
RGD ID:
3965
Description:
Enables calcium channel activity and identical protein binding activity. Involved in negative regulation of cell population proliferation. Located in endomembrane system; lamellipodium; and plasma membrane. Orthologous to human TRPV2 (transient receptor potential cation channel subfamily V member 2); INTERACTS WITH 11-hydroxy-Delta(9)-tetrahydrocannabinol; 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran.
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRPV2 mRNA
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of TRPV2 mRNA] and Mifepristone inhibits the reaction [bisphenol A results in decreased expression of TRPV2 protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRPV2 mRNA
Cannabidiol analog binds to and results in increased activity of TRPV2 protein and Cannabidiol binds to and results in increased activity of TRPV2 protein
[Clofibrate co-treated with Acetaminophen] affects the expression of TRPV2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TRPV2 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRPV2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRPV2 mRNA
[Clofibrate co-treated with Acetaminophen] affects the expression of TRPV2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TRPV2 mRNA]
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TRPV2 mRNA and PPARA protein promotes the reaction [pirinixic acid results in increased expression of TRPV2 mRNA]
Mifepristone inhibits the reaction [Progesterone results in decreased expression of TRPV2 mRNA] and Mifepristone inhibits the reaction [Progesterone results in decreased expression of TRPV2 protein]
Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.
